Patient aggression in hospitals contributes to nurse burnout and workforce attrition. Emerging AI-driven vocal biomarker technology may provide early detection, improving safety, response times, and staff well-being in clinical environments.
Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.
EY Entrepreneur Of The Year John Lippert founded Scientia Vascular to create purpose-built neurovascular devices that reduce stroke treatment times by 30 minutes. His microfabricated guidewires and catheters are transforming brain surgery with unprecedented precision.
Utah’s SEDI Summit (UVU - Orem, UT) explored state-endorsed digital identity, emphasizing governance, privacy, and security. Leaders and legislators discussed technical frameworks, policy strategies, and human impacts, charting a roadmap for safe, equitable digital identity systems.
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.
Patient aggression in hospitals contributes to nurse burnout and workforce attrition. Emerging AI-driven vocal biomarker technology may provide early detection, improving safety, response times, and staff well-being in clinical environments.
Philo Ventures (Lehi, UT) launches its $3M Sandbox Fund to back Utah student founders, providing pre-seed capital, mentorship, and early traction support, aiming to retain talent and strengthen the state’s innovation ecosystem.
EY Entrepreneur Of The Year John Lippert founded Scientia Vascular to create purpose-built neurovascular devices that reduce stroke treatment times by 30 minutes. His microfabricated guidewires and catheters are transforming brain surgery with unprecedented precision.
Altris (Salt Lake City, UT) has reinvented Nikola Tesla’s turbine, delivering compact, high-efficiency power for microgrids and data centers, bridging clean energy innovation with global impact, from Utah to Zambia.
Patient aggression in hospitals contributes to nurse burnout and workforce attrition. Emerging AI-driven vocal biomarker technology may provide early detection, improving safety, response times, and staff well-being in clinical environments.
Salt Lake City’s Power District breaks ground with Rocky Mountain Power’s 10-story HQ, signaling major westside redevelopment and a new mixed-use hub linking downtown, the airport, and Utah’s innovation economy.
Vector (Draper, UT), led by former Army aviator Andy Yakulis, secures a multi-million SOCOM contract, providing attritable drones via a subscription “Modern Warfare as a Service” model, with fiber-optic FPV integration, tactical training, and battlefield innovation showcased at the 47G Summit.
Element Ventures welcomes Sam Andersen as Investment Partner. Andersen will drive early-stage investments in Utah, building on the firm’s decade-long track record supporting successful startups across tech sectors.
Matia Mobility, co-founded by Steven Boal, delivers a groundbreaking standing device for paraplegics, restoring independence and dignity. FDA- and VA-approved, made in Utah, it transforms lives while navigating insurance and accessibility challenges.
EY Entrepreneur Of The Year John Lippert founded Scientia Vascular to create purpose-built neurovascular devices that reduce stroke treatment times by 30 minutes. His microfabricated guidewires and catheters are transforming brain surgery with unprecedented precision.
Utah’s SEDI Summit (UVU - Orem, UT) explored state-endorsed digital identity, emphasizing governance, privacy, and security. Leaders and legislators discussed technical frameworks, policy strategies, and human impacts, charting a roadmap for safe, equitable digital identity systems.
Salt Lake City biotech firm Seek Labs expands its AI-driven Global Disease Atlas to map hemorrhagic fever and orthopoxvirus families, advancing programmable CRISPR therapeutics for faster global outbreak response and prevention.